Intrinsic Bioprobes, Inc.



	Accelerate drug development Proteomics technology

   Intrinsic Bioprobes, Inc. provides high-content protein analysis
   services, enabling novel biomarker and proteomic discoveries.
   IBI characterizes proteins quickly and in high throughput, reducing
   development time and cutting bottom-line expenses.



		News Intrinsic Bioprobes develops novel mass spectrometry-based assay that reveals degradation and low levels of bioactive B-type Natriuretic Peptide (BNP) in patients with heart failure.



		Events IBI presented at the 2008 American Association for Cancer Research Annual meeting in San Diego, CA, April 12-16, 2008.



		Publications Detection of Endogenous B-Type Natriuretic Peptide at Very Low Concentrations in Patients with Heart Failure Investigation of human protein variants and their frequency in the general population

Home | Sitemap | Directions | Literature